Clinical impact of guideline-based practice and patients’ adherence in uncontrolled hypertension
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Chronic diseases like hypertension need comprehensive lifetime management. This study assessed clinical and patient-reported outcomes and compared them by treatment patterns and adherence at 6 months among uncontrolled hypertensive patients in Korea.This prospective, observational study was conducted at 16 major hospitals where uncontrolled hypertensive patients receiving anti-hypertension medications (systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg) were enrolled during 2015 to 2016 and studied for the following 6 months. A review of medical records was performed to collect data on treatment patterns to determine the presence of guideline-based practice (GBP). GBP was defined as: (1) maximize first medication before adding second or (2) add second medication before reaching maximum dose of first medication. Patient self-administered questionnaires were utilized to examine medication adherence, treatment satisfaction and quality of life (QoL). A total of 600 patients were included in the study. Overall, 23% of patients were treated based on GBP at 3 months, and the GBP rate increased to 61.4% at 6 months. At baseline and 6 months, 36.7 and 49.2% of patients, respectively, were medication adherent. The proportion of blood pressure-controlled patients reached 65.5% at 6 months. A higher blood pressure control rate was present in patients who were on GBP and also showed adherence than those on GBP, but not adherent, or non-GBP patients (76.8% vs. 70.9% vs. 54.2%, P < 0.001). The same outcomes were found for treatment satisfaction and QoL ( P < 0.05). This study demonstrated the importance of physicians’ compliance with GBP and patients’ adherence to hypertensive medications. GBP compliance and medication adherence should be taken into account when setting therapeutic strategies for better outcomes in uncontrolled hypertensive patients.
Abstract
Chronic diseases like hypertension need comprehensive lifetime management. This study assessed clinical and patient-reported outcomes and compared them by treatment patterns and adherence at 6 months among uncontrolled hypertensive patients in Korea.This prospective, observational study was conducted at 16 major hospitals where uncontrolled hypertensive patients receiving anti-hypertension medications (systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg) were enrolled during 2015 to 2016 and studied for the following 6 months. A review of medical records was performed to collect data on treatment patterns to determine the presence of guideline-based practice (GBP). GBP was defined as: (1) maximize first medication before adding second or (2) add second medication before reaching maximum dose of first medication. Patient self-administered questionnaires were utilized to examine medication adherence, treatment satisfaction and quality of life (QoL). A total of 600 patients were included in the study. Overall, 23% of patients were treated based on GBP at 3 months, and the GBP rate increased to 61.4% at 6 months. At baseline and 6 months, 36.7 and 49.2% of patients, respectively, were medication adherent. The proportion of blood pressure-controlled patients reached 65.5% at 6 months. A higher blood pressure control rate was present in patients who were on GBP and also showed adherence than those on GBP, but not adherent, or non-GBP patients (76.8% vs. 70.9% vs. 54.2%, P < 0.001). The same outcomes were found for treatment satisfaction and QoL ( P < 0.05). This study demonstrated the importance of physicians’ compliance with GBP and patients’ adherence to hypertensive medications. GBP compliance and medication adherence should be taken into account when setting therapeutic strategies for better outcomes in uncontrolled hypertensive patients.
참고문헌 (23)
- Rahimi K, "The epidemiology of blood pressure and its worldwide management", Circ Res, 116, pp.925~936 (2015)
- Mancia G, "2013ESH", ESC guidelines for the management of arterial hypertension : the task force for the management of arterial hypertension of the European Society of Hypertension(ESH)and of the European Society of Cardiology(ESC), 2013, pp.31, 1281~1357
- 신진호, "2013 Korean Society of Hypertension guidelines for the management of hypertension. Part II—treatments of hypertension", Clinical Hypertension, 21(2), pp.1~13 (2015), 대한고혈압학회[DOI]
- Lindholm LH, "The new Japanese Society of Hypertension guidelines for the management of hypertension(JSH 2014) : a giant undertaking", Hypertens Res, 37, pp.391~392 (2014)
- Weber MA, "Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension", J Hypertens, 32, pp.3~15 (2014)
- James PA, "2014 evidence-based guideline for the management of high blood pressure in adults : report from the panel members appointed to the eighth joint National Committee(JNC 8)", JAMA, 311, pp.507~520 (2014)
- Van Wijk BL, "Rate and determinants of 10-year persistence with antihypertensive drugs", J Hypertens, 23, pp.2101~2107 (2005)
- 김현진, "Medication Adherence and the Occurrence of Complications in Patients with Newly Diagnosed Hypertension", Korean Circulation Journal, 46(3), pp.384~393 (2016), 대한심장학회[DOI]
- Kim S, "Medication adherence and the risk of cardiovascular mortality and hospitalization among patients with newly prescribed antihypertensive medications", Hypertension, 67, pp.506~512 (2016)
- Simpson SH, "A meta-analysis of the association between adherence to drug therapy and mortality", BMJ, 333, pp.15~ (2006)
- Zyoud SH, "Relationship of treatment satisfaction to medication adherence : findings from a cross-sectional survey among hypertensive patients in Palestine", Health Qual Life Outcomes, 11, pp.191~ (2013)
- Trevisol DJ, "Health-related quality of life and hypertension : a systematic review and meta-analysis of observational studies", J Hypertens, 29, pp.179~188 (2011)
- Morisky DE, "Predictive validity of a medication adherence measure in an outpatient setting", J Clin Hypertens(Greenwich), 10, pp.348~354 (2008)
- Berlowitz DR, "Effect of intensive blood-pressure treatment on patient-reported outcomes", N Engl J Med, 377, pp.733~744 (2017)
- Bress AP, "Costeffectiveness of intensive versus standard blood-pressure control", N Engl J Med, 377, pp.745~755 (2017)
- Atkinson MJ, "Validation of a general measure of treatment satisfaction, the treatment satisfaction questionnaire for medication(TSQM), using a national panel study of chronic disease", Health Qual Life Outcomes, 2, pp.12~ (2004)
- Corrao G, "Discontinuation of and changes in drug therapy for hypertension among newly-treated patients : a population-based study in Italy", J Hypertens, 26, pp.819~824 (2008)
- Krousel-Wood M, "Predictors of decline in medication adherence : results from the cohort study of medication adherence among older adults", Hypertension, 58, pp.804~810 (2011)
- Naderi SH, "Adherence to drugs that prevent cardiovascular disease : meta-analysis on 376, 162 patients", Am J Med, 125, pp.882~887.e1 (2012)
- Corrao G, "Better compliance to antihypertensive medications reduces cardiovascular risk", J Hypertens, 29, pp.610~618 (2011)
- Whelton PK, "2017 ACC", AHA, ABC, pp.ACPM, AGS[DOI]
- Bundy JD, "Systolic blood pressure reduction and risk of cardiovascular disease and mortality : a systematic review and network meta-analysis", JAMA Cardiol, 2, pp.775~781 (2017)
- Ettehad D, "Blood pressure lowering for prevention of cardiovascular disease and death : a systematic review and meta-analysis", Lancet, 387, pp.957~967 (2016)